Article information
Full text is only aviable in PDF
Bibliografía
[1.]
J.L. Izquierdo Alonso, I. Sánchez Hernández, J. Fernández Francés, J. Castelao Naval, F. Carrillo Arias, J. Gallardo Carrasco.
Utility of transfer factor to detect different bronchodilator responses in patients with COPD.
Respiration, 65 (1998), pp. 282-288
[2.]
C.P. Van Schyck, P.N. Dekhuijzen, W.J. Gorgels, P.M. Van Grunsven, J. Molema, C.L. Van Herwaarden, C. Van Weel.
Are anti-oxidant and anti-inflammatory treatments effective in defferent subgroups of COPD?. A hypothesis.
Respir Med, 92 (1998), pp. 1.259-1.264
[3.]
M. Nisar, J.E. Earis, M.G. Pearson, P.M.A. Calverley.
Acute bronchodilator trials in chronic obstructive pulmonary disease.
Am Rev Respir Dis, 146 (1992), pp. 555-559
[4.]
V.M. Keatings, A. Jakatanon, A. Worsdell, Y.M. Worsdell, P.J. Barnes.
Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.
Am J Respir Crit Care Med, 155 (1997), pp. 542-548
[5.]
J.T. Wilcke, A. Dirksen.
The effect of inhaled glucocorticosteroids in emphysema due to alpha-1 antitrypsin deficiency.
Respir Med, 91 (1997), pp. 275-279
[6.]
E. Dompeling, C.P. Van Schayck, P.M. Van Grunsven, C.L. Van Herwaarden, R. Akkermanns, J. Molema, et al.
Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids: a 4 year prospective study.
Ann Intern Med, 118 (1993), pp. 770-778
[7.]
H.A.M. Kerstjens, P.L.P. Brand, M.D. Hughes, N.J. Robinson, D.S. Postma, H.J. Sluiter, et al.
A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airway disease.
N Engl J Med, 327 (1992), pp. 1.413-1.419
[8.]
C.G. Löfdahl, D.S. Postma, L.A. Laitinen, S.V. Ohlsson, R.A. Pauwels, N.B. Pride.
The European respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): recruitment methods and strategies.
Respir Med, 92 (1998), pp. 467-472
[9.]
P.L. Paggiaro, R. Dahle, I. Bakran, L. Frith, K. Hollingworth, J. Efthimiou.
Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease.
Lancet, 351 (1998), pp. 773-780
[10.]
P. Chanez, A.M. Vignola, T. O'Shaughnessy, I. Enander, D. Li, P.K. Jeffery.
Corticosteroid reversibility in COPD is related to features of asthma.
Am J Respir Crit Care Med, 155 (1997), pp. 1.529-1.534
[11.]
N.M. Siafakas, P. Vermiere, N.B. Pride, et al.
Optimal assessment and management of chronic obstructive pulmonary disease (COPD): European Respiratory Society consensus statement.
Eur Respir J, 8 (1995), pp. 1.398-1.420
[12.]
P. Weiner, M. Weiner, Y. Azgad, D. Zamir.
Inhaled budesonide therapy for patients with stable COPD.
Chest, 108 (1995), pp. 1.568-1.571
[13.]
W.D. Kim, D.H. Eidelman, J.L. Izquierdo, H. Ghezzo, P. Saetta, M.G. Costo.
Centrilobular and panlobular emphysema in smokers.
Am Rev Respir Dis, 144 (1991), pp. 1.385-1.390
Copyright © 1999. Sociedad Española de Neumología y Cirugía Torácica
